SNT:JSESantam Limited Analysis
Data as of 2026-06-26 - not real-time
ZAC 39,045.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Santam Ltd (SNT.JO) is trading at ZAc 39,045, comfortably above its 20‑day (ZAc 38,293) and 50‑day (ZAc 38,946) moving averages but still below the 200‑day average (ZAc 40,953), indicating short‑term momentum within a longer‑term bearish backdrop. The MACD histogram is positive (≈ 99.6) and the signal line is bullish, while the RSI sits at a neutral 52.8, suggesting limited downside pressure and room for a modest rally. Valuation metrics reinforce the upside case: the trailing P/E of 10.6 is well under the industry average of 16.9, and the DCF‑derived fair value of ZAc 210,019 implies a 16.4 % upside from current levels. Analysts consensus rates the stock as a “buy” with a median target of ZAc 44,780, translating to roughly 14 % potential gain.
The company delivers strong profitability, posting a ROE of 33 % and an operating margin of 18.7 %, while maintaining a healthy balance sheet with cash of ZAc 21.998 bn versus debt of ZAc 6.157 bn (debt‑to‑equity ≈ 37 %). Free cash flow of ZAc 12.978 bn and a dividend yield of 4.34 % (payout ratio ≈ 43 %) underscore the sustainability of its shareholder returns. Low systematic risk is reflected in a beta of 0.19, and the stock’s volatility over the past 30 days is moderate at 21.9 %, keeping price swings within manageable bounds. The fear‑and‑greed index at “Extreme Greed” (88.55) signals strong market appetite, yet the underlying fundamentals remain robust.
Geographic concentration in South Africa and the broader African market introduces medium‑level geographic risk, while the insurance sector’s regulatory environment warrants a medium regulatory risk rating. Currency exposure is limited, earning a low currency‑risk assessment, and the stock’s liquidity is solid, reflected by stable trading volumes and a market cap of ZAc 42.65 bn. Overall, the blend of attractive valuation, solid earnings growth, and dependable dividend income makes Santam a compelling buy for medium‑ and long‑term horizons. Investors should monitor the 40,518 resistance level and any shifts in macro‑economic conditions that could affect the South African insurance market.
The company delivers strong profitability, posting a ROE of 33 % and an operating margin of 18.7 %, while maintaining a healthy balance sheet with cash of ZAc 21.998 bn versus debt of ZAc 6.157 bn (debt‑to‑equity ≈ 37 %). Free cash flow of ZAc 12.978 bn and a dividend yield of 4.34 % (payout ratio ≈ 43 %) underscore the sustainability of its shareholder returns. Low systematic risk is reflected in a beta of 0.19, and the stock’s volatility over the past 30 days is moderate at 21.9 %, keeping price swings within manageable bounds. The fear‑and‑greed index at “Extreme Greed” (88.55) signals strong market appetite, yet the underlying fundamentals remain robust.
Geographic concentration in South Africa and the broader African market introduces medium‑level geographic risk, while the insurance sector’s regulatory environment warrants a medium regulatory risk rating. Currency exposure is limited, earning a low currency‑risk assessment, and the stock’s liquidity is solid, reflected by stable trading volumes and a market cap of ZAc 42.65 bn. Overall, the blend of attractive valuation, solid earnings growth, and dependable dividend income makes Santam a compelling buy for medium‑ and long‑term horizons. Investors should monitor the 40,518 resistance level and any shifts in macro‑economic conditions that could affect the South African insurance market.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and neutral RSI suggest limited near‑term upside
- Price trading above short‑term moving averages provides support
- Moderate volatility and low beta reduce short‑term risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to peers (P/E 10.6 vs industry 16.9)
- Strong earnings growth and ROE of 33 %
- Attractive dividend yield of 4.34 % with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust balance sheet with ample cash and manageable debt
- Consistent free cash flow supporting dividend sustainability
- Low systematic risk (beta 0.19) and solid market position in specialty insurance
Key Metrics & Analysis
Financial Health
Revenue Growth4.90%
Profit Margin6.63%
P/E Ratio10.6
ROE33.08%
ROA8.78%
Debt/Equity37.14
P/B Ratio2.8
Op. Cash FlowZAC2.4B
Free Cash FlowZAC13.0B
Industry P/E16.9
Technical Analysis
TrendBearish
RSI52.8
SupportZAC 36,011.00
ResistanceZAC 40,518.00
MA 20ZAC 38,293.60
MA 50ZAC 38,946.32
MA 200ZAC 40,952.88
MACDBullish
VolumeStable
Fear & Greed Index88.55
Valuation
Fair ValueZAC 210,018.73
Target PriceZAC 45,452.60
Upside/Downside16.41%
GradeUndervalued
TypeBlend
Dividend Yield4.34%
Risk Assessment
Beta0.19
Volatility21.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.